Patents by Inventor Robert K. Shepherd
Robert K. Shepherd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20260325832Abstract: The present disclosure relates to a peripheral nerve electrode array that includes a first, second and third pair of electrodes spaced from each other along a longitudinal axis of the electrode array, the second pair of electrodes being located between the first and third pairs of electrodes. The present disclosure further relates to method for treating or preventing a chronic inflammatory condition in a human subject in need thereof, comprising providing to the human subject a therapeutically effective electrical stimulation of the anterior central abdominal vagus nerve or the posterior central abdominal vagus nerve, wherein the electrical stimulation is provided through two or more previously implanted electrodes at a site below the cardiac branches and above the hepatic-celiac branches of the nerve; and whereby the chronic inflammatory condition is prevented or treated in the human subject.Type: ApplicationFiled: July 2, 2026Publication date: October 22, 2026Inventors: Robert K. Shepherd, James Fallon, Sophie Payne, Owen Burns, John Barton Furness
-
Patent number: 12734354Abstract: The present disclosure relates to a peripheral nerve electrode array that includes a first, second and third pair of electrodes spaced from each other along a longitudinal axis of the electrode array, the second pair of electrodes being located between the first and third pairs of electrodes. The present disclosure further relates to method for treating or preventing a chronic inflammatory condition in a human subject in need thereof, comprising providing to the human subject a therapeutically effective electrical stimulation of the anterior central abdominal vagus nerve or the posterior central abdominal vagus nerve, wherein the electrical stimulation is provided through two or more previously implanted electrodes at a site below the cardiac branches and above the hepatic-celiac branches of the nerve; and whereby the chronic inflammatory condition is prevented or treated in the human subject.Type: GrantFiled: November 3, 2021Date of Patent: September 15, 2026Assignee: THE BIONICS INSTITUTE OF AUSTRALIAInventors: Robert K. Shepherd, James Fallon, Sophie Payne, Owen Burns, John Barton Furness
-
Patent number: 12048733Abstract: The present invention relates to methods of treating an auditory disorder. In particular, the present invention relates to treating an auditory disorder using supraparticles comprising a therapeutic payload.Type: GrantFiled: May 25, 2022Date of Patent: July 30, 2024Assignees: THE BIONICS INSTITUTE OF AUSTRALIA, THE UNIVERSITY OF MELBOURNEInventors: Andrew Wise, Robert K. Shepherd, Frank Caruso
-
Publication number: 20220362337Abstract: The present invention relates to methods of treating an auditory disorder. In particular, the present invention relates to treating an auditory disorder using supraparticles comprising a therapeutic payload.Type: ApplicationFiled: May 25, 2022Publication date: November 17, 2022Inventors: Andrew Wise, Robert K. Shepherd, Frank Caruso
-
Patent number: 11413452Abstract: The present disclosure relates to a peripheral nerve electrode array that includes a first, second and third pair of electrodes spaced from each other along a longitudinal axis of the electrode array, the second pair of electrodes being located between the first and third pairs of electrodes. The present disclosure further relates to method for treating or preventing a chronic inflammatory condition in a human subject in need thereof, comprising providing to the human subject a therapeutically effective electrical stimulation of the anterior central abdominal vagus nerve or the posterior central abdominal vagus nerve, wherein the electrical stimulation is provided through two or more previously implanted electrodes at a site below the cardiac branches and above the hepatic-celiac branches of the nerve; and whereby the chronic inflammatory condition is prevented or treated in the human subject.Type: GrantFiled: April 9, 2020Date of Patent: August 16, 2022Assignee: THE BIONICS INSTITUTE OF AUSTRALIAInventors: Robert K. Shepherd, James Fallon, Sophie Payne, Owen Burns, John Barton Furness
-
Patent number: 11369661Abstract: The present invention relates to methods of treating an auditory disorder. In particular, the present invention relates to treating an auditory disorder using supraparticles comprising a therapeutic payload.Type: GrantFiled: July 1, 2019Date of Patent: June 28, 2022Assignees: THE BIONICS INSTITUTE OF AUSTRALIA, THE UNIVERSITY OF MELBOURNEInventors: Andrew Wise, Robert K. Shepherd, Frank Caruso
-
Publication number: 20220054825Abstract: The present disclosure relates to a peripheral nerve electrode array that includes a first, second and third pair of electrodes spaced from each other along a longitudinal axis of the electrode array, the second pair of electrodes being located between the first and third pairs of electrodes. The present disclosure further relates to method for treating or preventing a chronic inflammatory condition in a human subject in need thereof, comprising providing to the human subject a therapeutically effective electrical stimulation of the anterior central abdominal vagus nerve or the posterior central abdominal vagus nerve, wherein the electrical stimulation is provided through two or more previously implanted electrodes at a site below the cardiac branches and above the hepatic-celiac branches of the nerve; and whereby the chronic inflammatory condition is prevented or treated in the human subject.Type: ApplicationFiled: November 3, 2021Publication date: February 24, 2022Inventors: Robert K. Shepherd, James Fallon, Sophie Payne, Owen Burns, John Barton Furness
-
Publication number: 20200230400Abstract: The present disclosure relates to a peripheral nerve electrode array that includes a first, second and third pair of electrodes spaced from each other along a longitudinal axis of the electrode array, the second pair of electrodes being located between the first and third pairs of electrodes. The present disclosure further relates to method for treating or preventing a chronic inflammatory condition in a human subject in need thereof, comprising providing to the human subject a therapeutically effective electrical stimulation of the anterior central abdominal vagus nerve or the posterior central abdominal vagus nerve, wherein the electrical stimulation is provided through two or more previously implanted electrodes at a site below the cardiac branches and above the hepatic-celiac branches of the nerve; and whereby the chronic inflammatory condition is prevented or treated in the human subject.Type: ApplicationFiled: April 9, 2020Publication date: July 23, 2020Inventors: Robert K. Shepherd, James Fallon, Sophie Payne, Owen Burns, John Barton Furness
-
Publication number: 20200000879Abstract: The present invention relates to methods of treating an auditory disorder. In particular, the present invention relates to treating an auditory disorder using supraparticles comprising a therapeutic payload.Type: ApplicationFiled: July 1, 2019Publication date: January 2, 2020Inventors: Andrew Wise, Robert K. Shepherd, Frank Caruso
-
Publication number: 20190261912Abstract: Detecting of a disorder associated with impaired barrier function in the gastrointestinal tract of a subject is described, including through determining bioimpedance across a subject's gastrointestinal tract wall and detecting impaired barrier function based on bioimpedance. An electrical signal is measured between first and second electrodes, at least the first electrode being located in a gastrointestinal tract of the body and one or more characteristics are determined based on the measured electrical signal. The one or more characteristics can comprise hallmarks of impaired barrier function such as leakiness and/or permeability of the gastrointestinal tract and can provide an indication of inflammatory bowel disease and/or gut inflammation.Type: ApplicationFiled: September 29, 2017Publication date: August 29, 2019Inventors: Robert K. Shepherd, John Furness, James Fallon, Sophie Payne, Owen Burns